BioCentury
ARTICLE | Clinical News

BC Sera Dx: Phase II data

April 15, 2013 7:00 AM UTC

A Russian Phase II trial showed that OTraces' BC Sera Dx blood test was 98% accurate for detecting breast cancer in women. The company could not be reached for details or next steps. ...